ID 184A1 AC CVCL_3040 AS CVCL_8222 SY 184 A1; H184A1 DR CLO; CLO_0001137 DR EFO; EFO_0022348 DR ATCC; CRL-8798 DR BioSample; SAMN03471210 DR cancercelllines; CVCL_3040 DR DepMap; ACH-002319 DR GEO; GSM350522 DR GEO; GSM843436 DR GEO; GSM845393 DR GEO; GSM1172844 DR GEO; GSM1172932 DR IZSLER; BS CL 178 DR LINCS_HMS; 51088 DR LINCS_LDP; LCL-2080 DR PharmacoDB; 184A1_4_2019 DR Progenetix; CVCL_3040 DR Wikidata; Q54582476 RX DOI=10.1007/978-1-4612-0411-4_26; RX Patent=US4808532; RX PubMed=2702624; RX PubMed=3857588; RX PubMed=8504475; RX PubMed=9398663; RX PubMed=9671407; RX PubMed=12661003; RX PubMed=19582160; RX PubMed=24176112; RX PubMed=25960936; RX PubMed=28196595; RX PubMed=28889351; WW Info; -; -; https://hmec.lbl.gov/mreview.htm WW Info; MCLP; -; https://tcpaportal.org/mclp/ WW Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255 CC Group: Patented cell line. CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: JWGray breast cancer cell line panel. CC Part of: MD Anderson Cell Lines Project. CC Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8798. CC Doubling time: 58.07 hours (JWGray panel). CC HLA typing: A*02:01,02:01; B*18:01,18:01; C*07:01,07:01 (PubMed=25960936). CC Microsatellite instability: Stable (MSS) (PubMed=12661003). CC Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene. CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; CNV analysis. CC Omics: Variations; SNP array analysis. CC Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367. ST Source(s): ATCC=CRL-8798; IZSLER=BS CL 178; PubMed=28889351 ST Amelogenin: X ST CSF1PO: 10,11 ST D13S317: 11 ST D16S539: 11,12 ST D18S51: 12,14 ST D19S433: 14 ST D21S11: 29,30 ST D2S1338: 17,23 ST D3S1358: 15 ST D5S818: 11,13 ST D7S820: 9,11 ST D8S1179: 11,13 ST FGA: 19,22 ST Penta D: 12,13 ST Penta E: 7,14 ST TH01: 9.3 ST TPOX: 11 ST vWA: 18,19 OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_K049 ! 184 SX Female AG 21Y CA Transformed cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 32 CH CVCL_9665 ! 184A1N4 // RX Patent=US4808532; RA Stampfer, Martha Ruskin RT "Continuous human cell lines and method of making same."; RL Patent number US4808532, 28-Feb-1989. // RX PubMed=3857588; DOI=10.1073/pnas.82.8.2394; PMCID=PMC397564; RA Stampfer, Martha Ruskin RA Bartley, Jack C. RT "Induction of transformation and continuous cell lines from normal RT human mammary epithelial cells after exposure to benzo[a]pyrene."; RL Proc. Natl. Acad. Sci. U.S.A. 82:2394-2398(1985). // RX PubMed=28889351; DOI=10.1007/s10549-017-4496-x; RA Saunus, Jodi M. RA Smart, Chanel E. RA Kutasovic, Jamie R. RA Johnston, Rebecca L. RA Kalita-de Croft, Priyakshi RA Miranda, Mariska RA Rozali, Esdy N. RA Vargas, Ana Cristina RA Reid, Lynne E. RA Lorsy, Eva RA Cocciardi, Sibylle RA Seidens, Tatjana RA McCart Reed, Amy Ellen RA Dalley, Andrew J. RA Wockner, Leesa F. RA Johnson, Julie RA Sarkar, Debina RA Askarian-Amiri, Marjan E. RA Simpson, Peter T. RA Khanna, Kum Kum RA Chenevix-Trench, Georgia RA Al-Ejeh, Fares RA Lakhani, Sunil R. RT "Multidimensional phenotyping of breast cancer cell lines to guide RT preclinical research."; RL Breast Cancer Res. Treat. 167:289-301(2018). // RX PubMed=24176112; DOI=10.1186/gb-2013-14-10-r110; PMCID=PMC3937590; RA Daemen, Anneleen RA Griffith, Obi L. RA Heiser, Laura M. RA Wang, Nicholas J. RA Enache, Oana M. RA Sanborn, Zachary RA Pepin, Francois RA Durinck, Steffen RA Korkola, James E. RA Griffith, Malachi RA Hur, Joe S. RA Huh, Nam RA Chung, Jongsuk RA Cope, Leslie RA Fackler, Mary Jo RA Umbricht, Christopher Benedict RA Sukumar, Saraswati RA Seth, Pankaj RA Sukhatme, Vikas P. RA Jakkula, Lakshmi R. RA Lu, Yi-Ling RA Mills, Gordon B. RA Cho, Raymond J. RA Collisson, Eric A. RA van 't Veer, Laura J. RA Spellman, Paul T. RA Gray, Joe W. RT "Modeling precision treatment of breast cancer."; RL Genome Biol. 14:R110.1-R110.14(2013). // RX PubMed=9671407; DOI=10.1038/sj.onc.1201814; RA Sweeney, Kimberley J. RA Swarbrick, Alexander RA Sutherland, Robert Lyndsay RA Musgrove, Elizabeth A. RT "Lack of relationship between CDK activity and G1 cyclin expression in RT breast cancer cells."; RL Oncogene 16:2865-2878(1998). // RX PubMed=19582160; DOI=10.1371/journal.pone.0006146; PMCID=PMC2702084; RA Kao, Jessica RA Salari, Keyan RA Bocanegra, Melanie RA Choi, Yoon-La RA Girard, Luc RA Gandhi, Jeet RA Kwei, Kevin A. RA Hernandez-Boussard, Tina RA Wang, Pei RA Gazdar, Adi F. RA Minna, John D. RA Pollack, Jonathan R. RT "Molecular profiling of breast cancer cell lines defines relevant RT tumor models and provides a resource for cancer gene discovery."; RL PLoS ONE 4:e6146.1-e6146.16(2009). // RX PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981; RA Boegel, Sebastian RA Lower, Martin RA Bukur, Thomas RA Sahin, Ugur RA Castle, John C. RT "A catalog of HLA type, HLA expression, and neo-epitope candidates in RT human cancer cell lines."; RL OncoImmunology 3:e954893.1-e954893.12(2014). // RX PubMed=2702624; DOI=10.1016/0165-4608(89)90056-3; RA Walen, Kirsten H. RA Stampfer, Martha Ruskin RT "Chromosome analyses of human mammary epithelial cells at stages of RT chemical-induced transformation progression to immortality."; RL Cancer Genet. Cytogenet. 37:249-261(1989). // RX DOI=10.1007/978-1-4612-0411-4_26; RA Stampfer, Martha Ruskin RA Yaswen, Paul RA Parry, Gordon RA Hosoda, Junko RT "An in vitro human mammary epithelial model system for studies of RT differentiation and carcinogenesis."; RL (In book chapter) Neoplastic transformation in human cell system. Mechanism of carcinogenesis; Rhim, Johng Sik & Dritschilo, Anatoly (eds.); pp.259-267; Humana Press; New York; USA (1990). // RX PubMed=12661003; DOI=10.1002/gcc.10196; RA Seitz, Susanne RA Wassmuth, Peter RA Plaschke, Jens RA Schackert, Hans Konrad RA Karsten, Uwe RA Santibanez-Koref, Mauro F. RA Schlag, Peter Michael RA Scherneck, Siegfried RT "Identification of microsatellite instability and mismatch repair gene RT mutations in breast cancer cell lines."; RL Genes Chromosomes Cancer 37:29-35(2003). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, A. Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=8504475; DOI=10.1093/carcin/14.5.833; RA Lehman, Teresa A. RA Modali, Ramakrishna V. RA Boukamp, Petra RA Stanek, Julie RA Bennett, William P. RA Welsh, Judith A. RA Metcalf, Robert A. RA Stampfer, Martha Ruskin RA Fusenig, Norbert E. RA Rogan, Eileen M. RA Harris, Curtis Craig RT "p53 mutations in human immortalized epithelial cell lines."; RL Carcinogenesis 14:833-839(1993). // RX PubMed=9398663; DOI=10.1091/mbc.8.12.2391; PMCID=PMC25715; RA Stampfer, Martha Ruskin RA Bodnar, Andrea G. RA Garbe, James C. RA Wong, Michelle RA Pan, Alison RA Villeponteau, Bryant RA Yaswen, Paul RT "Gradual phenotypic conversion associated with immortalization of RT cultured human mammary epithelial cells."; RL Mol. Biol. Cell 8:2391-2405(1997). //